These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 20632309)

  • 1. 1α,25-dihydroxyvitamin D3 inhibits C4-2 prostate cancer cell growth via a retinoblastoma protein (Rb)-independent G1 arrest.
    Washington MN; Kim JS; Weigel NL
    Prostate; 2011 Jan; 71(1):98-110. PubMed ID: 20632309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1Alpha,25-dihydroxyvitamin D3 reduces c-Myc expression, inhibiting proliferation and causing G1 accumulation in C4-2 prostate cancer cells.
    Rohan JN; Weigel NL
    Endocrinology; 2009 May; 150(5):2046-54. PubMed ID: 19164469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of retinoblastoma protein (Rb) phosphorylation at serine sites and an increase in Rb-E2F complex formation by silibinin in androgen-dependent human prostate carcinoma LNCaP cells: role in prostate cancer prevention.
    Tyagi A; Agarwal C; Agarwal R
    Mol Cancer Ther; 2002 May; 1(7):525-32. PubMed ID: 12479270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiproliferative effect of 1alpha,25-dihydroxyvitamin D3 in human prostate cancer cell line LNCaP involves reduction of cyclin-dependent kinase 2 activity and persistent G1 accumulation.
    Zhuang SH; Burnstein KL
    Endocrinology; 1998 Mar; 139(3):1197-207. PubMed ID: 9492054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of a retinoblastoma-protein-dependent pathway by sphingosine.
    Dbaibo GS; Wolff RA; Obeid LM; Hannun YA
    Biochem J; 1995 Sep; 310 ( Pt 2)(Pt 2):453-9. PubMed ID: 7654183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effects of 1alpha,25-dihydroxyvitamin D(3) on the G(1)-S phase-controlling machinery.
    Jensen SS; Madsen MW; Lukas J; Binderup L; Bartek J
    Mol Endocrinol; 2001 Aug; 15(8):1370-80. PubMed ID: 11463860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Hsp90 function by ansamycins causes retinoblastoma gene product-dependent G1 arrest.
    Srethapakdi M; Liu F; Tavorath R; Rosen N
    Cancer Res; 2000 Jul; 60(14):3940-6. PubMed ID: 10919672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RB activity alters checkpoint response and chemosensitivity in lung cancer lines.
    Reed MF; Zagorski WA; Knudsen ES
    J Surg Res; 2007 Oct; 142(2):364-72. PubMed ID: 17640669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of insulin-like growth factor binding proteins in 1alpha,25-dihydroxyvitamin D(3)-induced growth inhibition of human prostate cancer cells.
    Stewart LV; Weigel NL
    Prostate; 2005 Jun; 64(1):9-19. PubMed ID: 15651061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct roles for p107 and p130 in Rb-independent cellular senescence.
    Lehmann BD; Brooks AM; Paine MS; Chappell WH; McCubrey JA; Terrian DM
    Cell Cycle; 2008 May; 7(9):1262-8. PubMed ID: 18418057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of the retinoblastoma tumor suppressor: differential action on transcriptional programs related to cell cycle control and immune function.
    Markey MP; Bergseid J; Bosco EE; Stengel K; Xu H; Mayhew CN; Schwemberger SJ; Braden WA; Jiang Y; Babcock GF; Jegga AG; Aronow BJ; Reed MF; Wang JY; Knudsen ES
    Oncogene; 2007 Sep; 26(43):6307-18. PubMed ID: 17452985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. pRb-Independent growth arrest and transcriptional regulation of E2F target genes.
    McCabe MT; Azih OJ; Day ML
    Neoplasia; 2005 Feb; 7(2):141-51. PubMed ID: 15802019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [miR-503-5p inhibits the proliferation of T24 and EJ bladder cancer cells by interfering with the Rb/E2F signaling pathway].
    Li X; Han X; Yang J; Sun J; Wei P
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Oct; 33(10):1360-1364. PubMed ID: 29169421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone morphogenetic protein-2 induces hypophosphorylation of Rb protein and repression of E2F in androgen-treated LNCaP human prostate cancer cells.
    Tomari K; Kumagai T; Shimizu T; Takeda K
    Int J Mol Med; 2005 Feb; 15(2):253-8. PubMed ID: 15647840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E2F-dependent regulation of human MYC: trans-activation by cyclins D1 and A overrides tumour suppressor protein functions.
    Oswald F; Lovec H; Möröy T; Lipp M
    Oncogene; 1994 Jul; 9(7):2029-36. PubMed ID: 8208548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficiency of G1 regulators P53, P21Cip1 and/or pRb decreases hepatocyte sensitivity to TGFbeta cell cycle arrest.
    Sheahan S; Bellamy CO; Dunbar DR; Harrison DJ; Prost S
    BMC Cancer; 2007 Nov; 7():215. PubMed ID: 18021445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D receptor agonists induce prostatic acid phosphatase to reduce cell growth and HER-2 signaling in LNCaP-derived human prostate cancer cells.
    Stewart LV; Lyles B; Lin MF; Weigel NL
    J Steroid Biochem Mol Biol; 2005 Oct; 97(1-2):37-46. PubMed ID: 16076555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The coupling of epidermal growth factor receptor down regulation by 1alpha,25-dihydroxyvitamin D3 to the hormone-induced cell cycle arrest at the G1-S checkpoint in ovarian cancer cells.
    Shen Z; Zhang X; Tang J; Kasiappan R; Jinwal U; Li P; Hann S; Nicosia SV; Wu J; Zhang X; Bai W
    Mol Cell Endocrinol; 2011 May; 338(1-2):58-67. PubMed ID: 21458521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulforaphane induces cell cycle arrest by protecting RB-E2F-1 complex in epithelial ovarian cancer cells.
    Bryant CS; Kumar S; Chamala S; Shah J; Pal J; Haider M; Seward S; Qazi AM; Morris R; Semaan A; Shammas MA; Steffes C; Potti RB; Prasad M; Weaver DW; Batchu RB
    Mol Cancer; 2010 Mar; 9():47. PubMed ID: 20196847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate derived factor in human prostate cancer cells: gene induction by vitamin D via a p53-dependent mechanism and inhibition of prostate cancer cell growth.
    Lambert JR; Kelly JA; Shim M; Huffer WE; Nordeen SK; Baek SJ; Eling TE; Lucia MS
    J Cell Physiol; 2006 Sep; 208(3):566-74. PubMed ID: 16741990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.